Prostate Cancer

Prostate cancer research group, co-led by assistant professor Antti Rannikko (clinical site) and associate professor Tuomas Mirtti (pathology and preclinical site) is the core of the Helsinki Prostate Cancer Research Center (PCRC).

Read more

Kidney Cancer

Kidney cancer research group is an active and growing group of researchers led by associate professor Harry Nisen (urology). The group has several retrospective and prospective studies and trials ongoing and on the pipeline. It actively collaborates with local, national and international experts in clinical, translational and preclinical collaborative projects.

Read more
virtsarakko-ikoni-turkoosi

Bladder Cancer

Bladder cancer group is co-led by urologist, PhD, Jukka Sairanen (invasive bladder cancer) and urologist, PhD, Riikka Järvinen (superficial bladder cancer).

The group has several retrospective and prospective studies and trials ongoing and on the pipeline. It actively collaborates with local, national and international experts in clinical, translational and preclinical collaborative projects.

Read more

Testicular Cancer

Testicular cancer research group is co-led by urologist, PhD, Hanna Vasarainen and associate professor Otto Hemminki.

Read more
penis-ikoni-turkoosi

Penile Cancer

Penile cancer research group is led by urologist, PhD, Hanna Vasarainen.

Read more

Helsinki Urological Cancer Research Center

Helsinki Urological Cancer Research Group centers around the clinical and academic work done at the HUS Helsinki University Hospital and Helsinki University. Department of urology is the largest in Finland with an catchment area of ca. 1.5M inhabitants and 25 staff members. Our center is a tertiary referral center for centralized surgery (e.g. Cystectomy, prostatectomy, urethraplasty, RPLND) but at the same time also responsible for the primary diagnostics, treatments and follow-up of all urological cancers in greater Helsinki area.

Read more
in association with

Twitter

Our first paper utilizing HUS Acamedic datalake for PCa research out👇Finding: less Bx complications after targeted Bx ONLY vs systematic Bx. Not powered for septic infections (16.000 needed, we only had 5K). @ProstatePioneer @IMI_EHDEN @LambAlastair https://pubmed.ncbi.nlm.nih.gov/35930069/

Lataa lisää...